Related references
Note: Only part of the references are listed.FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization
Shinichi Ishii et al.
BLOOD (2021)
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
Luis Toro et al.
KIDNEY INTERNATIONAL (2018)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
Erica L. Clinkenbeard et al.
HAEMATOLOGICA (2017)
FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis*
Lindsay M. Coe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
